Air purifier sales are are forecast to grow rapidly as people and institutions seek cleaner indoor air.
A greater focus on health and well-being is driving sales of products like air purifiers, with many people thinking these devices will make indoor air cleaner.
The U.S. air purifier market is forecast to grow at a compounded annualized rate of more than 8% during 2016 to 2021, according to a July report published by TechSci Research.
The report attributes this growth to “rising awareness about the impact of indoor pollution on human health, coupled with increasing incidence of respiratory diseases and rising awareness about health benefits of using air purifiers.”
The market is growing, even though health officials and consumer advocates say most people don’t need to own air purifiers for home use unless they have a serious lung condition like asthma or chronic obstructive pulmonary disease (COPD). Home purifiers, at best, supplement air quality, since most homes have enough leaks to allow sufficient air circulation between indoors and outdoors.
“Despite product claims, there is little definitive medical evidence that air purifiers help to relieve respiratory symptoms,” said Consumer Reports, which tested home air purifiers.
But that doesn't stop people from buying them, of course.
Although air purifiers in the home setting may have only limited utility, the bulk of the growth is in the commercial sector, where larger, more powerful cleaners are the norm.
The TechSci report says commercial use for these products far outweighs home demand. Sectors such as tourism, health care, and other institutions like embassies, hospitals, corporate offices, government buildings, schools, colleges, and so on are driving the growth. “[The] booming hospitality industry and scheduled inauguration of over 865 hotels in the U.S. by 2016 is projected to further boost demand for air purifiers in the country in the coming years,” the report said.
Not only does TechSci see strong growth in the U.S., but they also project a global desire for cleaner air, with sales expected to rise in places like China, India, and Saudi Arabia, among others.
A handful of companies are making air purifier filters and systems. Two of the major players, IQAir and Austin Air Systems, are privately held. There is interest in the space, however, from publicly held companies. Unilever (UN), for example, said in August that it's buying another major player, Blueair, as it sees the company’s premium air purification systems fitting in with Unilever’s water-purification business.
Because the purification market is a rather niche sector, no publicly traded company can be considered a pure play. Still, two firms in the space make highly rated purifiers and filters for both home and commercial use.
Whirlpool (WHR) and Honeywell (HON) both manufacture true high-efficiency particulate air (true HEPA) filters, which are proven to trap 99.97% of particles of 0.3 microns in size, plus the air purifiers that can handle these filters. Consumer Reports rated their products top buys.
Need to breathe some fresh air into your portfolio? The purification market might be just what the doctor ordered.
Use Stock Screener to narrow sector selections like health care and consumer discretionary. Log in at tdameritrade.com > Research & Ideas > Screeners > Stocks.
Debbie Carlson is not a representative of TD Ameritrade, Inc. The material, views, and opinions expressed in this article are solely those of the author and may not be reflective of those held by TD Ameritrade, Inc.
for thinkMoney ®
Financial Communications Society 2016
for Ticker Tape
Content Marketing Awards 2016
Content intended for educational/informational purposes only. Not investment advice, or a recommendation of any security, strategy, or account type.
Be sure to understand all risks involved with each strategy, including commission costs, before attempting to place any trade. Clients must consider all relevant risk factors, including their own personal financial situations, before trading.
Inclusion of specific security names in this commentary does not constitute a recommendation from TD Ameritrade to buy, sell, or hold.
Market volatility, volume, and system availability may delay account access and trade executions.
Past performance of a security or strategy does not guarantee future results or success.
Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses. Options trading subject to TD Ameritrade review and approval. Please read Characteristics and Risks of Standardized Options before investing in options.
Supporting documentation for any claims, comparisons, statistics, or other technical data will be supplied upon request.
This is not an offer or solicitation in any jurisdiction where we are not authorized to do business or where such offer or solicitation would be contrary to the local laws and regulations of that jurisdiction, including, but not limited to persons residing in Australia, Canada, Hong Kong, Japan, Saudi Arabia, Singapore, UK, and the countries of the European Union.
TD Ameritrade, Inc., member FINRA/SIPC, a subsidiary of The Charles Schwab Corporation. TD Ameritrade is a trademark jointly owned by TD Ameritrade IP Company, Inc. and The Toronto-Dominion Bank. © 2021 Charles Schwab & Co. Inc. All rights reserved.